First Cytogenetic Profle of Omani Patients with de novo Myelodysplastic Syndromes Comparison with data from Asia, Africa, Europe and North and South America

Journal Title: Sultan Qaboos University Medical Journal - Year 2017, Vol 17, Issue 3

Abstract

Clonal cytogenetic abnormalities have been reported among 30–80% of patients with myelodysplastic syndromes (MDS); however, 20–70% of patients with MDS show a normal karyotype that may nevertheless harbour a cryptic genetic alteration. Earlier reports have suggested that the distribution of specifc chromosomal aberrations varies among Western and Asian countries, with geographical and ethnic differences in the frequency of specifc chromosomal aberrations. Tis article compared the cytogenetic data of 36 adult Omani patients with MDS to previously reported data from other populations. Differences were noted between the percentages of clonal aberrations and the median age of Omani subjects at presentation in comparison to individuals of different ethnicities and from various geographical locations. To the best of the authors’ knowledge, this is the frst report to describe the cytogenetic data of patients with MDS from Oman.

Authors and Affiliations

Achandira M. Udayakumar| Departments of Genetics, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman; Department of Malignancy Cytogenetics & Molecular Pathology, Hammersmith Hospital, Imperial College Healthcare National Health Service Trust, London, UK, Nagla Fawaz| Departments of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman, Anil Pathare| Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman, Shakila Asraf| Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman, Mohammed Al-Huneini| Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman, Khalil Al-Farsi| Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman, Salam Al-Kindi| Departments of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman, Murtadha Al-Khabouri| Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman

Keywords

Related Articles

Re: Female Patients and Informed Consent: Oman’s cultural background

written in the language used most commonly in the country or region. If a patient cannot read or understand the language, a translation should be provided by professional medical translators.”1 Although the reasoning fo...

Clinical Audit of Diabetes Care in the Bahrain Defence Forces Hospital

Objectives: Primary care audits in Bahrain have consistently revealed a failure to meet recognised standards of delivery of process and outcome measures to patients with diabetes. Tis study aimed to establish for the f...

A Case of Intertriginous and Flexural Exanthema caused by Amoxicillin

We report a 50-year-old male patient who presented to the Dermatological Outpatient Clinic at the Hospital Universitario San Cecilio, Granada, Spain, in 2017 with symmetrical inguinal eruption and eruption on the dorsum...

Haemostatic Parameters in Patients with Behçet’s Disease

Objectives: Tis study aimed to evaluate the cause of thrombosis in Behçet’s disease (BD) patients, since abnormalities in coagulation and fbrinolytic parameters have shown contradictory results. Methods: Haemostatic...

Download PDF file
  • EP ID EP14791
  • DOI 10.18295/squmj.2017.17.03.005
  • Views 327
  • Downloads 19

How To Cite

Achandira M. Udayakumar, Nagla Fawaz, Anil Pathare, Shakila Asraf, Mohammed Al-Huneini, Khalil Al-Farsi, Salam Al-Kindi, Murtadha Al-Khabouri (2017). First Cytogenetic Profle of Omani Patients with de novo Myelodysplastic Syndromes Comparison with data from Asia, Africa, Europe and North and South America. Sultan Qaboos University Medical Journal, 17(3), 286-292. https://europub.co.uk/articles/-A-14791